Under the agreement, Dana-Farber will recruit physicians and other key personnel; advise St. Elizabeth’s on care for complex patients and support services; and improve the hospital’s IT system.
In turn, St. Elizabeth’s, which is part of Boston-based Steward Health Care System, must follow Dana-Farber’s treatment protocols for oncology patients and will pay Dana-Farber an undisclosed fee for its services. St. Elizabeth’s is also investing $5.5 million to renovate the hospital’s hematology and oncology unit as part of the agreement.
Related Articles on Hospital Oncology:
Study: Robotic Surgery No Better Than Open Surgery for Prostate Cancer
Study: Most Accelerated Partial Breast Irradiation Patients Unsuitable for Treatment
Study: Cancer Survivors Perceive Virtual Follow-up Visits Negatively
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
